Observational studyBMC cancer2021

Effect of antiangiogenic-based treatment and systemic inflammatory factors on outcomes in patients with BRAF v600-mutated metastatic colorectal cancer: a real-world study in Spain.

Nieves Martínez-Lago et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.